Point72 Hong Kong LTD Homology Medicines, Inc. Transaction History

Point72 Hong Kong LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.6 - $4.17 $12,368 - $19,836	-4,757 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$3.64 - $7.78 $17,315 - $37,009	4,757 New	4,757 $17,000
Q3 2020 Nov 16, 2020	SELL	$9.94 - $16.59 $22,146 - $36,962	-2,228 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$12.07 - $19.34 $26,891 - $43,089	2,228 New	2,228 $34,000
Q3 2019 Nov 14, 2019	SELL	$14.74 - $22.28 $4,790 - $7,241	-325 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$18.35 - $30.34 $5,963 - $9,860	325 New	325 $6,000

66.2K

Ticker FIXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 57,402,000
Description
Homology Medicines, Inc., a genetic medicines company, focuses on transforming the lives of patients suffering from rare genetic diseases. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nucleas...

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

Stay updated on Point72 Hong Kong LTD with notifications on news.